LXEO - Lexeo Therapeutics, Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LXEO is currently covered by 4 analysts with an average price target of $20.01. This is a potential upside of $15.11 (308.37%) from yesterday's end of day stock price of $4.9.

Lexeo Therapeutics, Common Stock's activity chart (see below) currently has 0 price targets and 16 ratings on display. The stock rating distribution of LXEO is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for LXEO is $24, Lowest price target is $19, average price target is $22.25.

Most recent stock forecast was given by LUCA ISSI from RBC on 21-Jan-2025. First documented stock forecast 28-Nov-2023.

Best performing analysts who are covering LXEO - Lexeo Therapeutics, Common Stock:

Mitchell Kapoor Geulah Livshits Luca Issi Mani Foroohar

Currently out of the existing stock ratings of LXEO, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$24

$19.1 (389.80%)

$24

7 months 2 days ago
(21-Jan-2025)

0/4 (0%)

$19.12 (391.80%)

Buy

$23

$18.1 (369.39%)

$21

9 months 9 days ago
(14-Nov-2024)

0/5 (0%)

$15.22 (195.63%)

Buy

$19

$14.1 (287.76%)

$20

9 months 10 days ago
(13-Nov-2024)

0/3 (0%)

$11.36 (148.69%)

Buy

$23

$18.1 (369.39%)

$23

9 months 24 days ago
(30-Oct-2024)

0/4 (0%)

$14.72 (177.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LXEO (Lexeo Therapeutics, Common Stock) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on LXEO (Lexeo Therapeutics, Common Stock) with a proven track record?

MITCHELL KAPOOR

Which analyst has the current lower performing score on LXEO (Lexeo Therapeutics, Common Stock) with a proven track record?

MANI FOROOHAR

Which analyst has the most public recommendations on LXEO (Lexeo Therapeutics, Common Stock)?

Mitchell Kapoor has 12 price targets and 7 ratings on LXEO

Which analyst is the currently most bullish on LXEO (Lexeo Therapeutics, Common Stock)?

Luca Issi with highest potential upside - $19.1

Which analyst is the currently most reserved on LXEO (Lexeo Therapeutics, Common Stock)?

Mani Foroohar with lowest potential downside - $14.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?